As part of its Morning Rounds series, a panel of specialists dives into the latest bladder cancer treatments, analyzing how recent clinical trial results are influencing their approach.
EP. 1: Case Study: Recognizing the Typical Signs of Bladder Cancer
Expert panelists unpack a patient's bladder cancer presentation, evaluating the presence of typical signs and symptoms that could lead to a diagnosis.
EP. 2: Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Experts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Becoming Familiar With Patients’ AEs is Essential, Says Expert
Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC
Tivozanib Combo Yields Similar PROs to Monotherapy in Advanced Clear Cell RCC
Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC